Le Lézard
Classified in: Health
Subjects: TDS, PET, FVT

Kindred Biosciences to Present at the Oppenheimer 28th Annual Healthcare Conference



SAN FRANCISCO, March 8, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the Oppenheimer 28th Annual Healthcare Conference on March 20-21, 2018 in New York City.

Kindred Biosciences, Inc. Logo

Denise Bevers, Co-Founder and Chief Operating Officer, will present and be available for one-on-one meetings at which investors will have the opportunity to discuss key therapeutic programs in development and upcoming milestones.

Presentation Details:

Date: Wednesday, March 21, 2018

Time: 2:10 - 2:40 PM EDT (11:10 - 11:40 AM PDT)

Location: The Westin New York Grand Central, Track 61 room

Webcase URL:  https://www.veracast.com/webcasts/opco/healthcare2018/15212424202.cfm

An archived version of the webcast will be available for 30 days on the Company's website: http://kindredbio.com/investor-relations/events/.

About Kindred Biosciences

Kindred Biosciences is a pre-commercialization stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.

For more information or to download the corporate presentation, visit www.KindredBio.com/LearnMore. Stay connected with KindredBio on Facebook at www.Facebook.com/KindredBio.

Contact
Russell Radefeld
KindredBio
russell.radefeld@kindredbio.com
(650) 701-7904

 

SOURCE Kindred Biosciences, Inc.


These press releases may also interest you

at 09:30
Crunch Franchise today announced the March 2019 opening of a $2.5 million, 31,000 square-foot fitness center with state-of-the-art equipment and amenities in Louisville, Kentucky. Crunch Dixie ? located in the Dixie Manor shopping center at 6801...

at 09:15
Ortho Regenerative Technologies Inc. ("Ortho RTi" or the "Corporation"), an emerging Orthopaedic and Sports Medicine technology company, announced that its recently completed study has been chosen by a peer reviewed panel as worthy of a podium...

at 09:15
The "Medical Image Management Market By Product (PACS (Radiology, Mammography, Cardiology, Oncology, Enterprise), VNA, AICA, Universal Viewer), Delivery (On Premise, Hybrid, Cloud), End User - Global Forecast to 2024" report has been added to...

at 09:05
Air Methods, the leading air medical service, today announced that it has donated $10,000 to the Brain Injury Association of America (BIAA) on behalf of Whitney Corby, an Air Methods patient who suffered a traumatic brain injury (TBI) and was...

at 09:00
NEW YORK, Dec. 12, 2018 /PRNewswire-PRWeb/ -- Long after the wound has healed, the pain of the scar can remain. "Especially if the scar is apparent," observes Dr. Valerie Goldburt, a dermatologist with Advanced Dermatology PC, "it can be a serious...

at 09:00
SAN FRANCISCO, Dec. 12, 2018 /PRNewswire-PRWeb/ -- uBiome, the leader in microbial genomics, announces the issue of patent number 9,663,831 entitled "Method and System for Microbiome Analysis" by the US Patent and Trademark Office on May 30, 2017...




News published on 8 march 2018 at 16:01 and distributed by: